E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Serum magnesium levels in type 2 diabetes with metabolic syndrome

K. C. Razeena, Jean Maliekkal, Geetha Nair.

Cited by (1)

Abstract
Background: Diabetes is a serious illness with multiple complications and premature mortality. Type 2 diabetes is the predominant form of diabetes worldwide, and it accounts for 90% of cases globally. Large majority with Type 2 diabetes have the metabolic syndrome (MS). MS is a widely prevalent disorder, and it is associated with increased risk for the development of cardiovascular disease, cerebrovascular disease, and renal disease.

Aims and Objectives: The present study was conducted to find out the relationship between serum magnesium levels and MS.

Materials and Methods: The study was conducted in 135 diabetic patients. They were divided into 2 groups. 90 Type 2 diabetic patients with MS and 45 Type 2 diabetic patients without MS. 45 normal healthy adults were included in the control group.

Results: The study showed that mean serum magnesium levels were significantly lower in patients with MS when compared with that of healthy adults. Correlation analysis revealed a significant negative correlation between serum magnesium levels and fasting blood sugar, systolic blood pressure (BP), diastolic BP, triglyceride levels, and a positive correlation between serum magnesium and high-density lipoprotein levels.

Conclusion: MS is highly prevalent in our population. Low serum magnesium levels play an important role in the pathogenesis of MS. Studies have shown that magnesium intake is inversely associated with incident MS and its components. Hence, magnesium supplementation in young adults can prevent the development of MS and thereby the complications related to it.

Key words: Magnesium; Metabolic Syndrome; Type 2 Diabetes


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by K. C. Razeena
Articles by Jean Maliekkal
Articles by Geetha Nair
on Google
on Google Scholar


REFERENCES
1. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, et al. Harrisons Principles of Internal Medicine. 17th ed., Vol. 11. New York: McGraw Hill; 1992-1995.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Diabetes Care. 1998;21(9):1414-31. https://doi.org/10.2337/diacare.21.9.1414 [Pubmed]   
3. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-74. https://doi.org/10.1056/NEJMoa031049 [Pubmed]   
4. Brown JE, Isaacs JS, Krinke UB. Nutrition Through The Life Cycle. 5th ed. Stamford: Cengage Learning; 2011-2014.
5. Grundy SM, H. Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109(3):433-8. https://doi.org/10.1161/01.CIR.0000111245.75752.C6 [Pubmed]   
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:S62-9.
7. Hans CP, Sialy R, Bensal DD. Magnesium deficiency and diabetes mellitus. Curr Sci. 2002;83(12):1456-63.
8. Kikuchi K, Tanaka H, Gima M, Kashiwagi Y, Shida H, Kawamura Y, et al. Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, Type 2 diabetes, heart failure and chronic hemodialysis. Clin Calcium. 2012;22(8):1217-26.
9. Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr. 2004;23(5):501S-5.
10. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002;39(4):209-13. https://doi.org/10.1007/s005920200036 [Pubmed]   
11. Evangelopoulos AA, Vallianou NG, Panagiotakos DB, Georgiou A, Zacharias GA, Alevra AN, et al. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res. 2008;28(10):659-63. https://doi.org/10.1016/j.nutres.2008.07.001 [Pubmed]   
12. Seelig MS. Metabolic syndrome - A complex of common diseases — Diabetes, hypertension, heart disease, dyslipidemia and obesity. Miner Resour Int. Available from: http:// www.mineralresourcesint.co.uk/pdf/Metabolic%20X%20 Syndrome.pdf. [Last accessed on 2016 Apr 28].
13. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res. 2007;20(2):107-29.
14. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN Jr. Serum magnesium and Type-2 diabetes in African Americans and Hispanics: A New York cohort. J Am Coll Nutr. 2006;25(6):509-13. https://doi.org/10.1080/07315724.2006.10719566 [Pubmed]   
15. Seyoum B, Siraj ES, Saenz C, Abdulkadir J. Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis. 2008;18(2):147-51.
16. Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulinmediated glucose disposal in non-diabetic subjects. J Clin Endocrinol Metab. 1997;82(11):3783-5.
17. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24(1-3):39-52.
18. Lima Mde L, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome – Evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009;83(2):257-62. https://doi.org/10.1016/j.diabres.2008.11.019 [Pubmed]   
19. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: Implications in hypertension. Am J Physiol Heart Circ Physiol. 2008;294(3):H1103-18.
20. Nozue T, Kobayashi A, Uemasu F, Takagi Y, Sako A, Endoh H. Magnesium status, serum HDL cholesterol, and apolipoprotein A-1 levels. J Pediatr Gastroenterol Nutr. 1995;20(3):316-8. https://doi.org/10.1097/00005176-199504000-00009 [Pubmed]   
21. Duffoo M. Magnesium in metabolic syndrome: Review of studies. Endocrinol Metab Syndr. 2016;5:1000219. https://doi.org/10.4172/2161-1017.1000219

This Article Cited By the following articles

Correlation of Serum Magnesium Level with Microalbuminuria in Type 2 Diabetes Mellitus
jebmh 2020; 7(32): 1617.

1
 
How to Cite this Article
Pubmed Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. Serum magnesium levels in type 2 diabetes with metabolic syndrome. Natl J Physiol Pharm Pharmacol. 2016; 6(6): 520-525. doi:10.5455/njppp.2016.6.0615307062016


Web Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. Serum magnesium levels in type 2 diabetes with metabolic syndrome. https://www.njppp.com/?mno=231710 [Access: December 01, 2022]. doi:10.5455/njppp.2016.6.0615307062016


AMA (American Medical Association) Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. Serum magnesium levels in type 2 diabetes with metabolic syndrome. Natl J Physiol Pharm Pharmacol. 2016; 6(6): 520-525. doi:10.5455/njppp.2016.6.0615307062016



Vancouver/ICMJE Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. Serum magnesium levels in type 2 diabetes with metabolic syndrome. Natl J Physiol Pharm Pharmacol. (2016), [cited December 01, 2022]; 6(6): 520-525. doi:10.5455/njppp.2016.6.0615307062016



Harvard Style

K. C. Razeena, Jean Maliekkal, Geetha Nair (2016) Serum magnesium levels in type 2 diabetes with metabolic syndrome. Natl J Physiol Pharm Pharmacol, 6 (6), 520-525. doi:10.5455/njppp.2016.6.0615307062016



Turabian Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. 2016. Serum magnesium levels in type 2 diabetes with metabolic syndrome. National Journal of Physiology, Pharmacy and Pharmacology, 6 (6), 520-525. doi:10.5455/njppp.2016.6.0615307062016



Chicago Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. "Serum magnesium levels in type 2 diabetes with metabolic syndrome." National Journal of Physiology, Pharmacy and Pharmacology 6 (2016), 520-525. doi:10.5455/njppp.2016.6.0615307062016



MLA (The Modern Language Association) Style

K. C. Razeena, Jean Maliekkal, Geetha Nair. "Serum magnesium levels in type 2 diabetes with metabolic syndrome." National Journal of Physiology, Pharmacy and Pharmacology 6.6 (2016), 520-525. Print. doi:10.5455/njppp.2016.6.0615307062016



APA (American Psychological Association) Style

K. C. Razeena, Jean Maliekkal, Geetha Nair (2016) Serum magnesium levels in type 2 diabetes with metabolic syndrome. National Journal of Physiology, Pharmacy and Pharmacology, 6 (6), 520-525. doi:10.5455/njppp.2016.6.0615307062016